|
Oct 11
|
Here’s What Dragged Novo Nordisk A/S (NVO) in Q3
|
|
Oct 11
|
Wegovy maker Novo Nordisk bets big on talent, AI partnerships in India
|
|
Oct 11
|
Warning: This Skyrocketing Stock Has a Hidden Risk
|
|
Oct 10
|
WeightWatchers stock soars, but its cheap Wegovy knockoff 'is not a sustainable long-term business model'
|
|
Oct 10
|
Update: Senator Warren Asks US Antitrust Regulator to 'Carefully Scrutinize' Novo Nordisk's Bid for Catalent
|
|
Oct 10
|
Senator Warren Asks US Antitrust Regulator to 'Carefully Scrutinize' Novo Nordisk's Bid for Catalent
|
|
Oct 10
|
US Senator Warren calls for scrutiny of Novo Holdings' Catalent deal
|
|
Oct 10
|
2 No-Brainer Dividend Growth Stocks to Buy Right Now
|
|
Oct 9
|
Novo Nordisk AS (NVO) Q2 2024 Earnings Call Highlights: Robust Sales Growth and Strategic ...
|
|
Oct 9
|
Offering Wegovy and other weight loss drugs on Medicare could cost $35 billion
|
|
Oct 9
|
Got $5,000? These 3 Growth Stocks Are on Sale Right Now.
|
|
Oct 9
|
Implied Volatility Surging for Novo Nordisk (NVO) Stock Options
|
|
Oct 9
|
Novo Nordisk A/S (NVO) Bullish on Wegovy Launch in International Markets
|
|
Oct 9
|
Ozempic and prescription weight loss drugs: How they work, what they cost, side effects, and everything to know
|
|
Oct 8
|
Novo Nordisk (NVO) Stock Declines While Market Improves: Some Information for Investors
|
|
Oct 8
|
WeightWatchers Stock Soars on Copycat Weight-Loss Drug Offering
|
|
Oct 8
|
WeightWatchers Is Offering Knockoff Wegovy. The Market Is Already Crowded.
|
|
Oct 8
|
Novo Nordisk Advances Share Buyback Program
|
|
Oct 8
|
Prediction: 3 of Wall Street's Most Influential Stocks Can Plunge if Kamala Harris Wins in November
|
|
Oct 3
|
Eli Lilly to Invest $4.5B for New Manufacturing & Research Plant
|